Human Granulocyte Colony-Stimulating Factor, CSF3 Primacu™ ELISA Kit

CAT:
772-BPE006-01
Size:
96 Well
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Human Granulocyte Colony-Stimulating Factor, CSF3 Primacu™ ELISA Kit - image 1

Human Granulocyte Colony-Stimulating Factor, CSF3 Primacu™ ELISA Kit

  • Background:

    Granulocyte-colony stimulating factor (G-CSF) is a growth factor and an essential cytokine belonging to the CSF family of hormone-like glycoproteins. It is produced by numerous cell types including immune and endothelial cells. G-CSF binding to its receptor G-CSF-R which belongs to the cytokine receptor type I family depends on the interaction of alpha-helical motifs of the former and two fibronectin type III as well as an immunoglobulin-like domain of the latter. Recent animal studies have also revealed that G-CSF activates multiple signaling pathways, such as Akt and also the Janus family kinase-2 and signal transducer and activation of transcription-3 (Jak2-STAT3) pathway, thereby promoting survival, proliferation, differentiation and mobilisation of haematopoietic stem and progenitor cells. G-CSF is a cytokine that have been demonstrated to improve cardiac function and perfusion in myocardial infarction. And it was initially evaluated as a stem cell mobilizer and erythropoietin as a cytoprotective agent. G-CSF prevents left ventricular remodeling after myocardial infarction by decreasing cardiomyocyte death and by increasing the number of blood vessels, suggesting the importance of direct actions of G-CSF on the myocardium rather than through mobilization and differentiation of stem cells. Accordingly, recombinant human (rh)G-CSF has been extensively used in clinical haematology and oncology to enable bone marrow transplantation or to treat chemotherapy-associated neutropenia. In preclinical study, G-CSF improved cardiac function and perfusion by angiomyogenesis and protection of cardiomyocytes in myocardial infarction. Cancer Immunotherapy Immune Checkpoint Immunotherapy Targeted Therapy
  • Description:

    Granulocyte colony-stimulating factor
  • Synonyms:

    C17orf33;GCSF
  • Gene Name:

    CSF3
  • Gene ID:

    1440
  • UniProt:

    P09919
  • Origin Species:

    Human
  • Reactivity:

    Human
  • Target:

    G-CSF
  • Field of Research:

    Cancer,Immunology,Neuroscience
  • Assay Type:

    Sandwich
  • Assay Performance Time:

    3.5 Hours
  • Standard:

    60 ng/mL
  • Sample Type:

    Serum, plasma, cell culture supernates
  • Detection Range:

    93.75-6000 pg/mL
  • Sensitivity:

    16.98 pg/mL
  • Weight:

    22293
  • Storage Temperature:

    2-8°C